Intracellular acidosis: Can it delay the inevitable? by Moseley, Richard H.








Cook JD, Lipschitz DA, Miles LEM, Finch CA. Serum ferritin as a 
measure of iron stores in normal subjects. Am J Clin Nutr 
Halliday JW, Powell LW. Ferritin metabolism and the liver. In: 
Powell LW, ed. Metals and the liver. New York Marcel Dekker Inc. 
Tsunetomi S, Ohto M, Iino Y, Shinagawa T, Kimura K, Morita M, 
Saisho H, e t  al. Diagnosis of small hepatocellular carcinoma by 
computed tomography: correlation of CT findings and histo- 
pathology. J Gastroenterol Hepatol 1989;4(5):395-404. 
Bradhear FtA, Bain C, SiskindV, Schofield FD, Webb S, Axelsen EM, 
Halliday JW, et al. Cohort study of internal malignancy in genetic 
hemochromatosis and other chronic non-alcoholic liver diseases. 
J Nat Canc Inst 1985;75:81-84. 
Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, 
Strohmeyer G. Survival and causes of death in cirrhotic and in 
non-cirrhotic patients with primary hemochromatosis. N Engl J 
Med 1985;313:1256-1262. 
Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani 
S, Morita M, et al. Natural history of minute hepatocellular 
carcinoma smaller than three centimeters complicating cirrhosis: a 
study in 22 patients. Gastroenterology 1986;90:289-298. 
1974;27:681-687. 
1978~53-91. 
INTRACELLULAR ACIDOSIS: CAN IT DELAY 
THE INEVITABLE? 
Gores G, Nieminen A-L, Wray BE, Herman B, Le- 
masters JJ. Intracellular pH during “chemical hypoxia” 
in cultured rat hepatocytes: protection by intracellular 
acidosis against the onset of cell death. J Clin Invest 
1989;83:386-396. 
ABSTRACT 
The relationships between extracellular pH (pH,), 
intracellular pH (pH,), and loss of cell viability were 
evaluated in cultured rat hepatocytes after ATP de- 
pletion by metabolic inhibition with KCN and io- 
doacetate (chemical hypoxia). pHi was measured in 
single cells by ratio imaging of 2’,7’-biscarbox~-ethyl- 
5,6-carboxyfluorescein (BCECF) fluorescence using 
multiparameter digitized video microscopy. During 
chemical hypoxia at pH, of 7.4, pHi decreased from 
7.36 to 6.33 within 10 min. pHi remained at 6.1-6.5 for 
30-40 min. (plateau phase). Thereafter, pHi began to 
rise and cell death ensued within minutes, as evi- 
denced by nuclear staining with propidium iodide and 
coincident leakage of BCECF from the cytoplasm. An 
acidic pH, produced a slightly greater drop in pH,, 
prolonged the plateau phase of intracellular acidosis, 
and delayed the onset of cell death. Inhibition of 
Na+/H+ exchange also prolonged the plateau phase 
and delayed cell death. In contrast, monensin or 
substitution of gluconate for Cl- in buffer containing 
HC0,- abolished the pH gradient across the plasma 
membrane and shortened cell survival. The results 
indicate that intracellular acidosis after ATP deple- 
tion delays the onset of cell death, whereas reduction 
of the degree of acidosis accelerates cell killing. We 
conclude that intracellular acidosis protects against 
hepatocellular death from ATP depletion, a phenom- 
enon that may represent a protective adaptation 
against hypoxic and ischemic stress. 
COMMENTS 
Hepatocytes possess membrane transport processes, 
such as Na+-H’ exchange (1) and Na+-HC0,- cotrans- 
port (21, that maintain intracellular pH (pH,) at levels 
well above that predicted by the Nernst equation. 
Numerous studies in other epithelia have demonstrated 
a relationship between pH, and cellular function. Acidic 
cytoplasmic conditions are typically associated with a 
quiescent or dormant cellular state and intracellular 
alkalinization frequently accompanies cellular growth 
and activation (3, 4). In contrast, the relationship 
between pH, and the structural and functional abnor- 
malities that occur during ischemic and hypoxic hepa- 
tocellular injury are less clear. 
Previous studies that examined the relationship be- 
tween extracellular pH (pH,) and hepatocyte injury 
suggested that acidosis may exert a protective effect 
(5, 6). The article under discussion extends these 
findings with the technological benefit (via multipa- 
rameter digitized video microscopy) of serial measure- 
ments of pHi in single cells. The advantages of this 
technique are readily apparent in the figures demon- 
strating the cellular localization of the probe used, 
2‘,7’-biscarboxyethy1-5, 6-carboxyfluorescein (BCECF), 
to the cytosol. This fluorescent probe, introduced into 
the cytosol in the form of the lipid-soluble acetoxymethyl 
ester where it is then cleaved by cytoplasmic esterases 
was assumed, in previous work, to be trapped in the 
cytosol. The cellular localization of BCECF is now 
confirmed by this elegant study using additional probes 
specific for lysosomes, endosomes and mitochondria and 
sequential dissolution of fluorescence by increasing 
concentrations of detergents. 
Hypoxia was induced by the administration of KCN 
and iodoacetate to inhibit oxidative phosphorylation and 
glycolysis, respectively, and thereby deplete cultured 
hepatocytes of ATP. Maneuvers that prolonged and/or 
increased intracellular acidosis protected against cell 
death during ATP depletion, including inhibition of 
Na’-H’ exchange by amiloride and by Na’ replacement 
and exposure of hepatocytes to acidic buffer. Conversely, 
cell death was accelerated by maneuvers that prevented 
a decrease in pHi. However, there are two potential 
disadvantages to this form of “chemical hypoxia.” The 
rapid decline in intracellular ATP levels (95% decrease 
within 5 min) that is observed may not duplicate the 
decrease that occurs in vivo during ischemic liver injury. 
Furthermore, the effect of iodoacetate-induced protein 
thiol alkylation is not addressed. 
The authors speculate that the effect of intracellular 
acidosis is a suppression of autolytic degradative pro- 
cesses. In support of this hypothesis they discuss 
unpublished observations of a similar protective effect of 
acidosis against cystamine-induced hepatotoxicity, an 
injury thought to involve activation of neutral proteases 
(7). Alterations in cellular Caz+ homeostasis have also 
been proposed to play a major role in ischemic cell injury, 
as recently reviewed (8), and cystamine hepatotoxicity 
has been demonstated to be mediated not only by 
activation of a nonlysosomal proteolytic system but 
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also by an inhibition of Ca2+ efflux (7). Although not 
discussed, these findings may provide a unifying theory 
of hepatocellular injury that incorporates both pertuba- 
tions in intracellular Ca2’ levels and pHi. 
Loss of plasma membrane integrity is an important 
feature in most schema of cell injury and several studies 
have correlated plasma membrane blebbing with hepa- 
tocellular injury (8). It is, therefore, somewhat discon- 
certing that the authors observed that acidic pH, does 
not prevent cell surface blebbing, scored with time-lapse 
video recordings of cultured hepatocytes. 
Finally, these findings, as well as those of previous 
work (6), may have important clinical implications for 
tissue preservation before orthotopic liver transplan- 
tation. If the conclusions of this work are accepted, then 
storage of donor livers in acidic media should enhance 
organ viability. However, it should be noted that the cold 
storage solution in current use, the “UW” solution, is of 
pH 7.4 and has been reported to extend appreciably the 
preservation of donor livers for transplantation (9). 
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INCREASED ENDOGENOUS 
NEUROPEPTIDE LIGAND FOR 
BENZODIAZEPINE RECEPTORS IN 
HEPATIC ENCEPHALOPATHY 
Rothstein JD, McKhann G, Guarneri P, Barbaccia 
ML, Guidotti A, Costa E.  Cerebrospinal fluid content of 
diazepam binding inhibitor in chronic hepatic enceph- 
alopathy. Ann Neurol 1989;26:57-62. 
ABSTRACT 
The neuropeptide diazepam binding inhibitor (DBI) 
is an endogeneous allosteric modulator of gamma- 
aminobutyric acid (GABA) receptors at the benzo- 
diazepine recognition site. Recent theories on the 
neurochemical cause for hepatic encephalopathy have 
implicated activation of inhibitory neurotransmitter 
GABA systems. In 20 patients with hepatic disease, 
blood and cerebrospinal fluid (CSF) levels of ammonia 
and amino acids were measured. As in previous studies 
there was a selective elevation of CSF amino acids as 
well as a correlation between CSF glutamine levels and 
encephalopathy. CSF DBI levels were maximally ele- 
vated &fold in patients with hepatic encephalopathy, 
but they were normal in those patients with liver 
disease not associated with changes in mental status 
and in patients with nonhepatic encephalopathy. 
Levels of DBI correlated with the clinical staging of 
hepatic encephalopathy. These data suggest that DBI 
may participate in the modulation of cerebral function 
in hepatic encephalopathy. 
COMMENTS 
The identification of specific receptors for the benzo- 
diazepines in mammalian brain in the 1970s led to 
intensive efforts by several research groups to identify 
the endogenous neurohormone (or ligand) for these 
receptors. The 1980s saw an ever growing list of 
candidate compounds that included beta-carbolines, 
hypoxanthines, porphyrins, neuropeptides and many 
others. Benzodiazepine-like immunoreactivity has been 
found in human brain samples stored in paraffin since 
1940,lO yr before the first synthesis of a benzodiazepine 
and 20 yr before its introduction onto the pharmaceu- 
tical market. This finding has led to the suggestion that 
benzodiazepine receptor ligands may be synthesized 
in situ or may be of dietary origin (1). 
In 1983, the polypeptide, diazepam binding inhibitor 
(DBI), which is capable of inhibiting 3-H-benzodiazepine 
binding, was isolated from rat brain (2). Behavioral 
pharmacological evaluation suggests that DBI acts as an 
inverse agonist of central benzodiazepine receptors, that 
is, brain benzodiazepine receptors that are functionally 
linked to the GABA-A receptor and chloride channels, 
producing anxiety and eliciting a proconflict response 
(i.e., a neurobehavioral test used in experimental an- 
imals to predict the anxiogenic or anxiolytic action of a 
drug). In the study of Rothstein et al. levels of DBI in 
cerebrospinal fluid (CSF) were measured in patients 
with hepatic encephalopathy (HE). A total of 20 patients 
were studied; 10 had biopsy-proven chronic active 
hepatitis, 7 had alcoholic cirrhosis, 2 had primary biliary 
cirrhosis and 1 had Wilson’s disease. Thirteen of these 
patients had chronic recurrent encephalopathy; the 
remaining 7 patients had no signs of encephalopathy. 
The degree of encephalopathy was monitored both 
neurologically and by EEG. DBI content of CSF was 
found to be elevated threefold in patients with HE, and 
